Amgen has announced plans to invest more than $600 million in a new, state-of-the-art centre for science ...
Amgen, a U.S.-based leader in biologic medicines, and NSG BioLabs, Singapore’s premier provider of biotechnology c...
"Robust growth in sales and earnings throughout 2024 reflects the momentum of our business. With strong performance glob...
From January to June 2024, Amgen demonstrated significant progress across various therapeutic areas, product lau...
NSG BioLabs, Singapore's largest biotech co-working biosafety level 2 laboratory provider, and Amgen, one of the world's...
Leading global biotechnology company Amgen and NSG BioLabs, Singapore’s largest and leading provider of biotechnol...
South Korea-based LegoChem Biosciences, Inc. (LCB) has entered into a research collaboration and license agree...
Fosun Pharma and Amgen have jointly announced a collaboration and license agreement for Fosun Pharma for the commerciali...
Amgen, a leading global biotechnology company, and NSG BioLabs, Singapore's largest and leading biotechno...
Bushu Pharmaceuticals has agreed on an expanded partnership with Amgen Inc. and Amgen K.K. to provide its "Gateway to As...
